Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
fEDr4n6XXZruV2js